Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Ensifentrine bulk supplier for pharma manufacturers

Ensifentrine 3 mg per 2.5 mL Suppliers & Bulk Manufacturers

Available Forms: Inhalation solution

Available Strengths: 3 mg per 2.5 mL

Reference Brands: Ohtuvayre (USA)

Category: Respiratory Disorder

Ensifentrine is a Respiratory Disorder product available as Inhalation solution in strengths 3 mg per 2.5 mL. It corresponds to the reference brand Ohtuvayre (USA). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Product Description:

Ensifentrine is an inhaled medication used for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adults. It is marketed under the brand name Ohtuvayre and represents a novel therapeutic approach by combining dual inhibition of phosphodiesterase 3 (PDE3) and phosphodiesterase 4 (PDE4) in a single molecule. This dual mechanism allows ensifentrine to deliver both bronchodilator and anti-inflammatory effects, addressing key pathological features of COPD.

As a PDE3 inhibitor, ensifentrine helps relax airway smooth muscle, leading to bronchodilation and improved airflow. At the same time, its PDE4 inhibitory activity reduces airway inflammation, which contributes to symptom control and disease management. Ensifentrine is administered by inhalation, allowing targeted delivery directly to the lungs and minimizing systemic exposure.

Ensifentrine is indicated for long-term COPD management and is used to improve lung function and reduce respiratory symptoms. Its inhaled formulation makes it suitable for patients who require consistent, localized therapy. By combining bronchodilation and anti-inflammatory action in one treatment, ensifentrine offers a differentiated and effective option for personalized respiratory care in adult COPD patients.

Ensifentrine — third party manufacturing & bulk supply

Ensifentrine 3 mg per 2.5 mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Manufacturers of Ensifentrine listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Ensifentrine →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions


Ensifentrine is used for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adults. It helps improve lung function and reduce respiratory symptoms associated with COPD.


Ensifentrine is a small-molecule, dual phosphodiesterase (PDE) inhibitor that selectively inhibits PDE3 and PDE4 enzymes involved in airway inflammation and bronchoconstriction.


The trade name of ensifentrine is Ohtuvayre.


Ensifentrine is developed and marketed by Verona Pharma.


The generic name is ensifentrine.


The brand name is Ohtuvayre.


Ensifentrine is manufactured in GMP-compliant pharmaceutical facilities for commercial supply in the United States.

Related Products

Salmeterol Xinafoate

Strength:
25 µg, 50 µg

Form: Inhalation

Reference Brands: Serevent (USA/LATAM/EU)

View Details
Formoterol Fumarate

Strength:
12 µg

Form: Inhalation

Reference Brands: Foradil (USA/LATAM), Oxis (India)

View Details
Ethionamide

Strength:
250 mg

Form: Tablets

Reference Brands: Generic formulations marketed under different names

View Details
Olodaterol

Strength:
2.5 mcg

Form: Inhalation solution

Reference Brands: Striverdi Respimat (USA)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.